KRAS wt Allele
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery (NCT01787500) | M.D. Anderson Cancer Center | 2013-02-15 |
Track KRAS wt Allele automatically
Every clearance here is in the API, with alerts when new ones post.